U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H16BrFN6O4
Molecular Weight 467.249
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MK-8245

SMILES

OC(=O)CN1N=NC(=N1)C2=CC(=NO2)N3CCC(CC3)OC4=CC(F)=CC=C4Br

InChI

InChIKey=UJEAABFSXKCSGI-UHFFFAOYSA-N
InChI=1S/C17H16BrFN6O4/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27/h1-2,7-8,11H,3-6,9H2,(H,26,27)

HIDE SMILES / InChI

Molecular Formula C17H16BrFN6O4
Molecular Weight 467.249
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22101133

Merck was developing MK 8245, an orally active inhibitor of stearoyl CoA desaturase for the treatment of type-2 diabetes mellitus. MK-8245 is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. It is in Phase 2 clinical studies for type 2 diabetes mellitus.

Originator

Curator's Comment: # Merck & Co

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.
2011 Jul 28
Patents

Sample Use Guides

50 mg capsules twice daily for 13 days.
Route of Administration: Oral
MK-8245 exhibits a significant SCD inhibition in the rat hepatocyte assay which contains functional, active OATPs with IC50 of 68 nM, while being only weakly active in the HepG2 cell assay which is devoid of active OATPs with IC50 of ~1 uM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:50:42 GMT 2023
Edited
by admin
on Sat Dec 16 07:50:42 GMT 2023
Record UNII
537E7QE8LX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MK-8245
Common Name English
2H-TETRAZOLE-2-ACETIC ACID, 5-(3-(4-(2-BROMO-5-FLUOROPHENOXY)-1-PIPERIDINYL)-5-ISOXAZOLYL)-
Common Name English
Code System Code Type Description
CAS
1030612-90-8
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
DRUG BANK
DB13024
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID80145625
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
FDA UNII
537E7QE8LX
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
PUBCHEM
24988881
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
SMS_ID
300000041505
Created by admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY